Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT02831855

Public ClinicalTrials.gov record NCT02831855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3B/4 RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF METHOTREXATE (MTX) WITHDRAWAL IN SUBJECTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH TOFACITINIB 11MG MODIFIED RELEASE (MR) FORMULATION

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified release formulation plus continued methotrexate treatment in subjects with moderate to severe rheumatoid arthritis who are insufficiently responding to their stable dose of methotrexate treatment.

Study identification

NCT ID
NCT02831855
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
694 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2016 (Actual)
Primary completion
Nov 19, 2018 (Actual)
Completion
Dec 17, 2018 (Actual)
Last update posted
Dec 4, 2019

2016 – 2018

United States locations

U.S. sites
59
U.S. states
22
U.S. cities
51
Facility City State ZIP Site status
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801-4418 —
Arthrocare, Arthritiscare & Research, PC Gilbert Arizona 85234 —
SunValley Arthritis Center, Ltd. Peoria Arizona 85381 —
CHI St. Vincent Medical Group Hot Springs Hot Springs Arkansas 71913 —
Med Investigations, Inc Fair Oaks California 95628 —
HCP Clinical Research, LLC Huntington Beach California 92646 —
Sierra Rheumatology Roseville California 95661 —
Pacific Arthritis Center Medical Group Santa Maria California 93454 —
Robin K. Dore, MD, Inc. Tustin California 92780 —
Inland Rheumatology and Osteoporosis Medical Group Upland California 91786 —
Inland Rheumatology Clinical Trials, Inc. Upland California 91786 —
Desert Valley Medical Group Victorville California 92395 —
AARDS Research Inc Aventura Florida 33180 —
RASF-Clinical Research Inc Boca Raton Florida 33486 —
Omega Research Consultants DeBary Florida 32713 —
University of Florida College of Medicine - Jacksonville - Rheumatology Research Jacksonville Florida 32207 —
University of Florida, Rheumatology at ACC Jacksonville Florida 32209 —
Center for Arthritis and Rheumatic Diseases Miami Florida 33173 —
Jeffrey Alper, MD Naples Florida 34102 —
Medallion Clinical Research Institute, LLC Naples Florida 34102 —
Suncoast Clinical Research, Inc. New Port Richey Florida 34652 —
Florida Arthritis & Osteoporosis Center Port Richey Florida 34668 —
Gulf Coast Medical Center Port Richey Florida 34668 —
West Broward Rheumatology Associates, Inc. Tamarac Florida 33321 —
USF Health Morsani Center for Advanced Healthcare Tampa Florida 33612 —
BayCare Medical Group, Inc Tampa Florida 33614 —
Institute of Arthritis Research Idaho Falls Idaho 83404 —
Quincy Medical Group Quincy Illinois 62301 —
Beacon Medical Group Rheumatology Main Street Granger Indiana 46530 —
Diagnostic Rheumatology and Research, PC Indianapolis Indiana 46227 —
Ochsner Clinic Baton Rouge Baton Rouge Louisiana 70836 —
Phase III Clinical Research Fall River Massachusetts 02720 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
Bronson Internal Medicine and Rheumatology Battle Creek Michigan 49015 —
Western Michigan University Homer Stryker MD Kalamazoo Michigan 49007 —
North Mississippi Medical Clinics, Inc. - Clinical Research Tupelo Mississippi 38801 —
Arthritis & Osteoporosis Associates Freehold New Jersey 07728 —
Radnet Marlton New Jersey 08053 —
Arthritis, Rheumatic & Back Disease Associates, P.A. Voorhees Township New Jersey 08043 —
Open MRI & Diagnostic Imaging of Wall Wall New Jersey 07719 —
AAIR Research Center Rochester New York 14618 —
Physicians East, PA Greenville North Carolina 27834 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
Trinity Health Center-Medical Arts Minot North Dakota 58701 —
Group Health Associates Cincinnati Ohio 45236 —
Cincinnati Rheumatic Disease Study Group, Inc. Cincinnati Ohio 45242 —
STAT Research, Inc. Dayton Ohio 45417 —
Health Research of Oklahoma Oklahoma City Oklahoma 73103 —
Oklahoma Medical Research Foundation (OMRF) Oklahoma City Oklahoma 73104 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
East Penn Rheumatology Associates, P.C. Bethlehem Pennsylvania 18015 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Piedmont Arthritis Clinic Greenville South Carolina 29601 —
Articularis Healthcare Group dba ACME Research Orangeburg South Carolina 29118 —
Articularis Healthcare Group d/b/a Low Country Rheumatology Summerville South Carolina 29486 —
Pioneer Research Solutions, Inc. Cypress Texas 77429 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Center for Arthritis and Rheumatic Diseases Chesapeake Virginia 23320 —
Center for Arthritis and Rheumatic Diseases Suffolk Virginia 23435 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02831855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02831855 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →